Hence, we experimentally confirmed the possible oncogenic function of KDM5B in HCC and found that KDM5B regulates the YTHDF3/ITGA6 axis by inhibiting the expression of miR‐448 to promote the occurrence of HCC (Figure 7). Here, KDM5B is linked to hepatocellular carcinoma.